Darbepoetin alfa Completed Phase 4 Trials for Chemotherapy / Anemia Treatment

Indications	Status	Purpose	Phase
DBCOND0020513 (Chemotherapy) DBCOND0020261 (Anemia)	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00315484	Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia	Darbepoetin alfa (DB00012) Erythropoietin (DB00016)